CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $78,656,000 | -44.6% | 2,678,128 | -14.2% | 1.15% | -48.1% |
| Q2 2018 | $141,954,000 | +681.3% | 3,121,925 | +1315.9% | 2.22% | +522.7% |
| Q3 2017 | $18,168,000 | -47.6% | 220,487 | -40.4% | 0.36% | -61.8% |
| Q2 2017 | $34,656,000 | -45.9% | 370,141 | -63.2% | 0.93% | -41.8% |
| Q1 2017 | $64,082,000 | +12.8% | 1,006,472 | -21.3% | 1.60% | +0.2% |
| Q4 2016 | $56,807,000 | +105.2% | 1,278,855 | +66.5% | 1.60% | +97.4% |
| Q3 2016 | $27,690,000 | +1.6% | 768,090 | -61.3% | 0.81% | -1.3% |
| Q2 2016 | $27,256,000 | -24.3% | 1,986,582 | +6.0% | 0.82% | -25.9% |
| Q1 2016 | $35,988,000 | -50.5% | 1,874,384 | -9.8% | 1.11% | -49.8% |
| Q4 2015 | $72,745,000 | -69.0% | 2,078,440 | -18.6% | 2.21% | -66.5% |
| Q3 2015 | $234,763,000 | -1.6% | 2,552,887 | -5.9% | 6.60% | +9.4% |
| Q2 2015 | $238,477,000 | +41.7% | 2,713,661 | +19.7% | 6.04% | +30.1% |
| Q1 2015 | $168,261,000 | +74.2% | 2,266,756 | +31.4% | 4.64% | +105.6% |
| Q4 2014 | $96,607,000 | +67.7% | 1,725,126 | +35.8% | 2.26% | +70.1% |
| Q3 2014 | $57,617,000 | +212.9% | 1,270,209 | +185.6% | 1.33% | +260.3% |
| Q2 2014 | $18,416,000 | -75.3% | 444,734 | -58.7% | 0.37% | -72.8% |
| Q1 2014 | $74,591,000 | -52.1% | 1,076,820 | -58.3% | 1.35% | -56.8% |
| Q4 2013 | $155,708,000 | +26.3% | 2,583,508 | +27.5% | 3.13% | +5.5% |
| Q3 2013 | $123,236,000 | -9.2% | 2,026,908 | +0.1% | 2.97% | +5.3% |
| Q2 2013 | $135,665,000 | +905.6% | 2,025,456 | +330.4% | 2.82% | +531.8% |
| Q1 2013 | $13,491,000 | – | 470,562 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |